article thumbnail

Signal: UK Biobank raises £32m in funding via public-private partnership

Pharmaceutical Technology

Eric Schmidt and Ken Griffin have led the UK Biobank funding round, donating a government-matched $10m each that may be used for AI.

article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK Biobank releases largest-ever genome sequencing dataset

pharmaphorum

UK Biobank releases largest-ever genome sequencing dataset Phil.Taylor Thu, 30/11/2023 - 10:00 Bookmark this

article thumbnail

UK Biobank study “will shape drug discovery”

pharmaphorum

UK Biobank study “will shape drug discovery” Phil.Taylor Thu, 05/10/2023 - 10:09 Bookmark this

article thumbnail

Biobanks VS Biorepositories: The Difference

Cloudbyz

The short answer is that all Biobanks are Biorepositories, but not all Biorepositories are Biobanks. Realistically speaking, the terms “Biobank” and “Biorepository” are used pretty interchangeably. The differences we can point out when someone asks: What is the difference between Biobanks and Biorepositories?

article thumbnail

Oxford Nanopore and UK to develop pathogen surveillance system

Pharmaceutical Technology

This initiative brings together UK Biobank, Genomics England, NHS England, and Oxford Nanopore to accelerate genomics-based research in the UK.

article thumbnail

UK Agency targets blood thinners in personalised medicine pursuit

Pharmaceutical Technology

The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.